This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Aizawa Y, Murata M, Hayashi M, Funazaki T, Ito S, Shibata A (1985) Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery. Jpn J Physiol 49:584–588
Amezcua JL, Palmer RMJ, De Souza BM, Moncada S (1989) Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 97:1119–1124
Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988a) Effect of vasoactive intestinal peptide on myocardial contracility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J Cardiovasc Pharmacol 12:365–371
Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988b) Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. Am J Physiol 255:H601–H607
Ando J, Kamatsuda T, Kamiya A (1988) Cytoplasmic calcium response to fluid shear stress in cultured vascular endothelial cells. In Vitro Cell Develop Biol 24:871
Angus JA, Cocks TM (1989) Endothelium-derived relaxing factor. Pharmacol Ther 41:303–351
Armour JA, Randall WC (1971) Canine left ventricular intramyocardial pressures. Am J Physiol 220:1833–1839
Arnold G, Kosche F, Miessner E, Neitzert A, Lochner W (1968) The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart. Pfluegers Arch 299:339–356
Ashton JH, Benedict CR, FitzGerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT (1986) Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 73:572–578
Aversano T, Becker LC (1985) Persistence of coronary vasodilator reserve despite functionally significant flow reduction. Am J Physiol 248:H403–H411
Bache RJ, Cobb FR (1977) Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res 41:648–653
Bache RJ, Schwartz JS (1982) Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 65:928–935
Bache RJ, Cobb FR, Greenfield Jr JC (1974) Myocardial blood flow distribution during ischemia-induced coronary vasodilation in the unanesthetized dog. J Clin Invest 54:1462–1472
Bardenheuer H, Schrader J (1983) Relationship between myocardial oxygen consumption, coronary flow, and adenosine release in an improved isolated working heart preparation of guinea pigs. Circ Res 51:263–271
Bassenge E (1984) Physiologie der Koronardurchblutung. In: Roskamm H (ed) Handbuch der inneren Medizin. Koronarerkrankungen. Springer, Berlin Heidelberg New York, pp 1–48
Bassenge E (1989) Flow-dependent regulation of coronary vasomotor tone. Eur Heart J 10 (Suppl F):22–27
Bassenge E, Busse R (1988) Endothelial modulation of coronary tone. Prog Cardiovasc Dis 30:349–380
Basenge E, Pohl U (1986) Two principles of large artery dilation: indirect endothelium-mediated and direct smooth muscle relaxation. In: Magro E, Osswald W, Reis O, Vanhoutte P (eds) Central and peripheral mechanisms of cardiovascular regulation. Nato Adv Sci Inst Series A: Life Science. Plenum, New York, pp 163–196
Bassenge E, Walter P, Doutheil U (1967) Wirkungsumkehr der adrenergischen Coronargefässreaktion in Abhägigkeit vom Coronargefässtonus. Pfluegers Arch 297:146–155
Bassenge E, Werle E, Holtz J, Fritz H (1969) Significance of kinins in the coronary circulation. Pharmacol Res Comm 1:136–137
Bassenge E, Werle E, Walter P, Holtz J (1970) Significance of kinins in the coronary circulation. Adv Exp Med Biol 8:141–148
Bassenge E, Kucharczyk M, von Restorff W, Werle E (1972) Effect of bradykinin potentiating peptide on coronary circulation in conscious dogs. Adv Exp Med Biol 21:251–157
Bassenge E, Busse R, Pohl U (1987) Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor. Circ Res 61 (Suppl II):II–68–II–73
Bassenge E, Busse R, Pohl U (1989) Hemmung der Thrombozytenaggregation und-adhäsi-on durch EDRF und deren pathophysiologische Bedeutung. Z Kardiol 78 (Suppl 6):54–58
Bayliss WM (1902) On the local reaction of the arterial wall to changes of internal pressure. J Physiol 28:220–231
Bellamy RF (1978) Diastolic coronary artery pressure-flow relations in the dog. Circ Res 43:92–101
Bellamy RF (1980) Calculation of coronary vascular resistance. Cardiovasc Res 14:261–269
Belloni FL, Bruttig SP, Rubio R, Berne RM (1986) Uptake and release of adenosine by cultured rat aortic smooth muscle. Microvasc Res 32:200–210
Berkenboom GM, Unger P (1990) Alpha-adrenergic coronary constriction in effort angina. Basic Res Cardiol (in press)
Berkenboom GM, Abramowicz M, Vandermoten P, Degre SG (1986) Role of alpha-adrenergic coronary tone in exercise-induced angina pectoris. Am J Cardiol 57:195–198
Berne RM (1958) Effect of epinephrine and norepinephrine on coronary circulation. Circ Res 6:644–655
Berne RM (1961) Nucleotide degradation in the hypoxic heart and its possible relation to regulation of coronary blood flow. Fed Proc 20:101 (abstract)
Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204:317–322
Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807–813
Berne RM, Rubio R (1979) Coronary circulation. In: Handbook of Physiology. The cardiovascular system I. American Physiological Society, Maryland, pp 873–952
Berne RM, Blackmon JR, Gardner TH (1957) Hypoxemia and coronary blood flow. J Clin Invest 36:1101–1106
Berne RM, DeGeest H, Levy MN (1965) Influence of the cardiac nerves on coronary resistance. Am J Physiol 208:763–769
Boeynaems JM (1988) Drugs influencing the vascular production of prostacyclin. Prostaglandins 34:197–204
Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ (1987a) Electrical stimulation in perifornical lateral hypothalamus decreases coronary blood flow in cats. Am J Physiol 252:H474–H484
Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ (1987b) Neurogenic regulation of coronary blood flow: evidence for a central nervous system pathway. Circ Res 61 (Suppl II):II–42–II–46
Borchard F (1978) The adrenergic nerves of the normal and the hypertrophied heart. Thieme, Stuttgart
Bossaller C, Yamamoto H, Henry PD (1986) Endothelium-dependent relaxation is depressed in atherosclerotic arteries in vivo. Z Kardiol 75 (Suppl 4):63 (abstract)
Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD (1987) Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 79:170–174
Boulanger C, Lüscher TF (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587–590
Bretschneider HJ (1967) Aktuelle Probleme der Koronardurchblutung und des Myokardstoffwechsels. Regensburger Jbl Aerztl Fortb 15:1–27
Broderick R, Bialecki R, Tulenko TN (1989) Cholesterol-induced changes in rabbit arterial smooth muscle sensitivity to adrenergic stimulation. Am J Physiol 257:H170–H178
Brown BG, Lee AB, Bolson EL, Dodge HT (1984a) Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 70:18–24
Brown BG, Bolson EL, Dodge HT (1984b) Dynamic mechanisms in human coronary stenosis. Circulation 70:917–922
Brum JM, Sufan Q, Dewey J, Bove AA (1985) Effects of angiotensin and ergonovine on large and small coronary arteries in the intact dog. Basic Res Cardiol 80:333–342
Buck JD, Hardman HF, Warltier DC, Gross GJ (1981) Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis induced by beta blockade in the canine heart. Circulation 64:708–715
Buckberg GD, Fixler DE, Archie Jr JP, Hoffman JIE (1972) Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 30:67–81
Buffington CW, Feigl EO (1981) Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res 48:416–423
Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, van Maercke TM, Herman AG (1990) Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (in press)
Burnstock G (1989) Vascular control by purines with emphasis on the coronary system. Eur Heart J 10 (Suppl F):15–21
Busch P, Deussen A, Heusch G (1988) Sympathetic effects on segmental coronary resistances and their role in coronary collateral perfusion. J Appl Cardiol 3:145–160
Buss DD, Wüsten B, Schaper W (1978) Effects of coronary stenoses and ventricular loading conditions on coronary flow. Basic Res Cardiol 73:571–583
Busse R, Mülsch A (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS 265:133–136
Busse R, Trogisch G, Bassenge E (1985) The role of endothelium in the control of vascular tone. Basic Res Cardiol 80:475–490
Busse R, Lückhoff A, Bassenge E (1987) Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch Pharmacol 336:566–571
Cambridge D, Davey MJ, Massingham R (1977) Prazosin, a selective antagonist of post-synaptic α-adrenoceptors. Br J Pharmacol 59:514P–515P
Canty JM (1988) Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res 63:821–836
Canty JM, Klocke FJ (1985) Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation 71:370–377
Carbonell LF, Carretero OA, Stewart JM, Scicli AG (1988) Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension 11:239–243
Carlsson L, Abrahamsson T (1989) Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium. Eur J Pharmacol 166:157–164
Case RB, Greenberg H (1976) The response of canine coronary vascular resistance to local alterations in coronary arterial pCO2. Circ Res 39:558–566
Case RB, Felix A, Wachter M, Kyriakidis G, Castellana F (1978) Relative effect of CO2 on canine coronary vascular resistance. Circ Res 42:410–418
Cavero I, Dennis T, Lefevre-Borg F, Perrot P, Roach AG, Scatton B (1979) Effects of clonidine, prazosin and phentolamine on heart rate and coronary sinus catecholamine concentration during cardioaccelerator nerve stimulation in spinal dogs. Br J Pharmacol 67:283–292
Cernacek P, Stewart DJ (1989) Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Comm 161:562–567
Chen DG, Dai X-Z, Zimmerman BG, Bache RJ (1988) Postsynaptic α1-and α2-adrenergic mechanisms in coronary vasoconstriction. J Cardiovasc Pharmacol 11:61–67
Chester A, Dashwood MR, Clarke J, Larkin S, Davies GJ, Tadjkarmi S, Maseri A, Yacoub M (1989) Influence of endothelin on human coronary arteries and localization of its binding sites. Am J Cardiol 63:1395–1398
Chierchia S, De Caterina R, Brunelli C, Crea F, Patrono C, Maseri A (1982) Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina. Circulation 62:702–705
Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A (1984) α-adrenergic receptors and coronary spasm: an elusive link. Circulation 69:8–14
Chierchia S, Pratt T, DeCoster P, Maseri A (1985) Alpha-adrenergic control of collateral flow: another determinant of coronary flow reserve. Circulation 72 (Suppl III):190 (abstract)
Chilian WM, Ackell PH (1988) Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis. Circ Res 62:216–225
Chilian WM, Layne SM (1990a) Coronary microvascular responses to reductions in perfusion pressure. Evidence for persistent arteriolar vasomotor tone during coronary hypoperfusion. Circ Res 66:1227–1238
Chilian WM, Layne SM (1990b) Coronary arteriolar α2-adrenergic constriction. FASEB J 4:A 1070 (abstract)
Chilian WM, Marcus ML (1985) Effects of coronary and extravascular pressure on intramyocardial and epicardial blood velocity. Am J Physiol 248:H170–H178
Chilian WM, Boatwright RB, Shoji T, Griggs DM (1981) Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res 49:866–876
Chilian WM, Harrison DG, Haws CW, Snyder WD, Marcus ML (1986) Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels. Circ Res 58:68–82
Chilian WM, Eastham CL, Layne SM, Marcus ML (1988) Small vessel phenomena in the coronary microcirculation: phasic intramyocardial perfusion and coronary microvascular dynamics. Prog Cardiovasc Dis 31:17–38
Chilian WM, Layne SM, Eastham CL, Marcus ML (1989) Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circ Res 64:376–388
Chu A, Stakely A, Cobb FR (1987) Nitrate-like effects of atrial natriuretic peptide on the coronary vasculature. Circulation 76 (Suppl IV):IV-240 (abstract)
Chu A, Cobb FR, Hagen PO, Murray JJ (1989a) Effects of a stabilized endothelium-derived relaxing factor on coronary vasculature in awake dogs. Am J PHysiol 257:H1895–H1899
Chu A, Chambers D, Lin C-C, Kuehl W, Cobb FR (1989b) Nitric oxide significantly alters basal coronary vasomotor tone in the awake dog. Circulation 80 (Suppl II):II-124 (abstract)
Chu A, Morris K, Kuehl W, Cusma J, Navetta F, Cobb FR (1989c) Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation 80:1627–1635
Clarke JG, Kerwin R, Larkin S, Lee Y, Yacoub M, Davies GJ, Hackett D, Dawbarn D, Bloom SR, Maseri A (1987) Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet I:1057–1059
Clarke JG, Benjamin N, Larkin SW, Webb DJ, Keogh BE, Davies GJ, Maseri A (1989) Endothelin is a potent long-lasting vasoconstrictor in man. Am J Physiol 257:H2033–H2035
Clozel J-P, Clozel M (1989) Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 65:1193–1200
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–629
Cocks TM, Angus JA, Campbell GR (1985) Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol 123:310–320
Cohen MV, Kirk ES (1973) Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Circ Res 33:445–453
Cohen RA (1986) Role of autonomic nerves and endothelium in coronary vasospasm. In: Tulenko T (ed) Recent advances in arterial diseases: atheroslerosis, hypertension, and vasospasm. Liss, New York, pp 353–362
Cohen RA (1988) Platelet 5-hydroxytryptamine and vascular adrenergic nerves. News Physiol Sci 3:185–189
Cohen RA, Cunningham LD (1988) Low density lipoproteins inhibit endothelium-dependent relaxations caused by bradykinin in the pig coronary artery. Circulation 78 (Suppl II):II-183 (abstract)
Cohen RA, Weisbrod RM (1988) Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. Am J Physiol 254:H871–H878
Cohen RA, Shepherd JT, Vanhoutte PM (1983a) Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 221:273–274
Cohen RA, Shepherd JT, Vanhoutte PM (1983b) Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries. Circ Res 52:16–25
Cohen RA, Shepherd JT, Vanhoutte PM (1984) Effects of the adrenergic transmitter on epicardial coronary arteries. Fed Proc 43:2862–2870
Cohen RA, Zitnay KM, Weisbrod RM (1987) Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res 61:829–833
Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD (1988) Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 63:903–910
Collier J, Vallance P (1989) Endothelium-derived relaxing factor is an endogenous vasodilator in man. Br J Pharmacol 97:639–641
Collins P, Sheridan D (1985) Improvement in angina pectoris with alpha adrenoceptor blockade. Br Heart J 53:488–492
Connaughton S, Docherty JR (1988) Evidence that SK and F 104078 does not differentiate between pre-and postjunctional α2-adrenoceptors. Naunyn Schmiedebergs Arch 338:379–382
Connaughton S, Docherty JR (1990) No evidence for differences in pre-and postjunctional α2-adrenoceptors in the periphery. Br J Pharmacol 99:97–102
Constantine JW, Lebel W (1980) Complete blockade by phenoxybenzamine of alpha 1-but not of alpha 2-vascular receptors in dogs and the effect of propranolol. Naunyn Schmiedebergs Arch Pharmacol 314:149–156
Constantine JW, Weeks RA, McShane WK (1978) Prazosin and presynaptic α-receptors in the cardioaccelerator nerve of the dog. Eur J Pharmacol 50:51–60
Cooke JP, Rossitch Jr E, Anden E, Loscalzo J, Dzau VJ (1990) Flow activates a specific endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (in press)
Cox DA, Hintze TH, Vatner SF (1983) Effects of acetylcholine on large and small coronary arteries in conscious dogs. J Pharmacol Exp Ther 225:764–769
Cross CE, Rieben PA, Salisbury PF (1961) Influence of coronary perfusion and myocardial edema on pressure-volume diagram of left ventricle. Am J Physiol 201:102–108
Crossman DC, Larkin SW, Fuller RW, Davies GJ, Maseri A (1989) Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 80:475–484
Dai X-Z, Herzog CA, Schwartz JS, Bache RJ (1986) Coronary blood flow during exercise following nonselective and selective α1-adrenergic blockade with indoramin. J Cardiovasc Pharmacol 8:574–581
Daly RN, Hieble JP (1987) Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechansim. Eur J Pharmacol 138:445–446
Daniell HB, Carson RR, Ballard KD, Thomas GR, Privitera PJ (1984) Effects of captopril on limiting infarct size in conscious dogs. J Cardiovasc Pharmacol 6:1043–1047
Dart AM, Schömig A, Dietz R, Mayer E, Kübler W (1984) Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ Res 55:702–706
Daugherty A, Zweifel BS, Sobel BE, Schonfeld G (1988) Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis 8:768–777
Daut J, Maier-Rudolph W, van Beckerath N, Mehrke G, Günther K, Goedel-Meinen L (1990) Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341–1344
Decker N, Schwartz PJ (1985) Postjunctional alpha1-and alpha2-adrenoceptors in the coronaries of the perfused guinea-pig heart. J Pharmacol Exp Ther 232:251–257
Denn MJ, Stone HL (1976) Autonomic innervation of dog coronary arteries. J Appl Physiol 41:30–35
De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797–9800
Deussen A, Heusch G, Thämer V (1985) Alpha 2-adrenoceptor-mediated coronary vasoconstriction persists after exhaustion of coronary dilator reserve. Eur J Pharmacol 115:147–153
Deussen A, Möser G, Schrader J (1986) Contribution of coronary endothelial cells to cardiac adenosine production. Pfluegers Arch 406:608–614
Deussen A, Borst M, Kroll K, Schrader J (1988) Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion. Circ Res 63:250–261
Deussen A, Lloyd HGE, Schrader J (1989) Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J Mol Cell Cardiol 21:773–782
De Witt DF, Wangler RD, Thompson CI, Sparks HV Jr (1983) Phasic release of adenosine during steady state metabolic stimulation in the isolated guinea pig heart. Circ Res 53:636–643
Dole WP (1987) Autoregulation of the coronary circulation. Prog CArdiovasc Disc 29:293–323
Dole WP, Bishop VS (1982) Influence of autoregulation and capacitance on diastolic coronary artery pressure-flow relationships in the dog. Circ Res 51:261–270
Dole WP, Nuno DW (1986) Myocardial oxygen tension determines the degree and pressure range of coronary autoregulation. Circ Res 59:202–215
Dole WP, Yamada N, Bishop VS, Olsson RA (1985) Role of adenosine in coronary blood flow regulation after reductions in perfusion pressure. Circ Res 56:517–524
Domenech RJ, de la Prida JM (1975) Mechanical effects of heart contraction on coronary flow. Cardiovasc Res 9:509–514
Downey HF, Bashour FA, Boatwright RB, Parker PE (1975) Uniformity of transmural perfusion in anesthetized dogs with maximally dilated coronary circulations. Circ Res 37:111–117
Downey JM, Kirk ES (1975) Inhibition of coronary blood flow by a vascular waterfall mechanism. Circ Res 36:753–760
Doxey JC, Roach AG, Smith CFC (1983) Studies on RX 781 094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 78:489–505
Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T (1989) Flow-dependent coronary artery dilatation in humans. Circulation 80:466–474
Driscol TE, Moir TW, Eckstein RW (1964) Vascular effect of changes in perfusion pressure in the nonischemic and ischemic heart. Circ Res 14/15 (Suppl I): I94–I102
Dull RO, Davies PF (1989) Featured Research: Endothelial regulation of vascular tone. Circulation 80 (Suppl II): II-481 (abstract)
Dusting GJ (1984) Coronary vasomotor tone: the role of prostanoids re-examined. Bibl Cardiol 38:178–188
Dusting GJ, Moncada S, Vane JR (1979) Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems. Prog Cardiovasc Dis 21:405–430
Dzau VJ (1988) Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77 (Suppl I):I4–I13
Edlund A, Berglund B, van Dorne D, Kaijser L, Nowak J, Patrono C, Sollevi A, Wennmalm A (1985) Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostacyclin formation. Circulation 71:1113–1120
Ehring T, Heusch G (1990) Felodipine prevents the poststenotic myocardial ischemia induced by α2-adrenergic coronary constriction. Cardiovasc Drugs Ther 4:443–450
Eikens E, Wilcken DEL (1974) Reactive hyperemia in the dog heart: effects of temporarily restricting arterial inflow and of coronary occlusions lasting one and two cardiac cycles. Circ Res 35:702–712
Ellis AK, Klocke FJ (1979) Effects of preload on the transmural distribution of perfusion and pressure-flow relationships in the canine coronary vascular bed. Circ Res 46:68–77
Ertl G (1987) Coronary vasoconstriction in experimental myocardial ischemia. J Cardiovasc Pharmacol 9 (Suppl 2):S9–S17
Ertl G, Kloner RA, Alexander RW, Braunwald E (1982) Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 65:40–48
Evers AS, Murphree S, Saffitz JE, Jakschik BA, Needleman P (1985) Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 75:992–999
Ezra D, Laurindo FRM, Eimerl J, Goldstein RE, Peck CC, Feuerstein G (1986) Tachykinin modulation of coronary blood flow. Eur J Pharmacol 122:135–138
Ezra D, Laurindo FRM, Goldstein DS, Goldstein RE, Feuerstein G (1987) Calcitonin gene-related peptide: a potent modulator of coronary flow. Eur J Pharmacol 137:101–105
Ezra D, Goldstein RE, Czaja JF, Feuerstein GZ (1989) Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 257:H339–H343
Faber JE (1988) In situ analysis of α-adrenoceptors in arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62:37–50
Fam WM, McGregor M (1968) Effect of nitroglycerin and dipyridamole on regional coronary resistance. Circ Res 22:649–659
Fauler J, Frölich JC (1989) Cardiovascular effects of leukotrienes. Cardiovasc Drugs Ther 3:499–505
Feigl EO (1968) Carotid sinus reflex control of coronary blood flow. Circ Res 23:223–237
Feigl EO (1969) Parasympathetic control of coronary blood flow in dogs. Circ Res 25:509–519
Feigl EO (1975) Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res 37:88–95
Feigl EO (1983) Coronary physiology. Physiol Rev 63:1–205
Feigl EO (1987) The paradox of adrenergic coronary vasoconstriction. Circulation 76:737–745
Feldman RD, Christy JP, Paul ST, Harrison DG (1989) β-adrenergic receptors on canine coronary collateral vessels: characterization and function. Am J Physiol 257:H1634–H1639
Fiedler VB, Abram TS (1987) Effects of intracoronary leukotriene D4 infusion on the coronary circulation, hemodynamics, and prostanoid release in porcine experiments. Cardiology 74:89–99
Fiedler VB, Mardin M, Abram TS (1984) Leukotriene D4-induced vasoconstriction of coronary arteries in anaesthetized dogs. Eur Heart J 5:253–260
Fischell TA, Nellessen U, Johnson DE, Ginsburg R (1989) Endothelium-dependent arterial vasoconstriction after balloon angioplasty. Circulation 79:899–910
Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P (1988) Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest 81:21–31
Fitscha P, Kaliman J, Sinzinger H (1985) Gamma-camera imaging after autologous human platelet labeling with 111In-oxine-sulfate: a key for assessing the efficacy of prostacyclin treatment in active atherosclerosis? In: Schrör K (ed) Prostaglandins and other eicosanoids in the cardiovascular system. Karger, Basel, pp 352–357
FitzGerald GA, Smith B, Pederson AK, Brash AR (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310:1065–1068
Fleckenstein A, Fleckenstein-Grün G (1988) Mechanism of action of calcium antagonists in heart and vascular smooth muscle. Eur Heart J 9 (Suppl H):95–99
Fleckenstein A, Nakayama K, Fleckenstein-Grün G, Byon YK (1975) Interactions of vasoactive ions and drugs with Ca-dependent excitation-contraction coupling of vascular smooth muscle. North Holland, Amsterdam, pp 555–566
Folkow B (1952) A study of the factors influencing the tone of denervated blood vessels perfused at various pressures. Acta Physiol Scand 27:99–117
Folkow B (1964) Description of the myogenic hypothesis. Circ Res 14/15 (Suppl I):I279–I287
Folts JD, Crowell Jr EB, Rowe GG (1976) Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54:365–370
Förster W (1980) Effect of various agents on prostaglandin biosynthesis and the anti-aggregatory effect. Acta Med Scand 642[Suppl]6:35–46
Förstermann U, Mülsch A, Böhme E, Busse R (1986) Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58:531–538
Förstermann U, Mügge A, Alheid U, Haverich A, Frölich JC (1988) Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 62:185–190
Franco-Cereceda A (1989) Endothelin-and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries. Br J Pharmacol 97:968–972
Franco-Cereceda A, Lundberg JM, Dahlöf C (1985) Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand 124:361–369
Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG (1986) Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58:783–789
Friedman PL, Brown EJ, Gunther S, Alexander RW, Barry WH, Mudge GH, Grossman W (1981) Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med 305:1171–1175
Fukuda K, Hori S, Kusuhara M, Satoh T, Kyotani S, Handa S, Nakamura Y, Oono H, Yamaguchi K (1989) Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur J Pharmacol 165:301–304
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Furlong B, Hendersen AH, Lewis MJ, Smith JA (1987) Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90:687–692
Fuster V, Steele PM, Chesebro JH (1985) Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 5:175B–184B
Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73:865–876
Gallagher KP, Matsuzaki M, Osakada G, Kemper WS, Ross Jr J (1983) Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res 52:716–729
Gallagher KP, Osakada G, Kemper WS, Ross Jr J (1985) Cyclical coronary flow reductions in conscious dogs equipped with ameroid constrictors to produce severe coronary narrowing. Basic Res Cardiol 80:100–106
Galle J, Bassenge E, Busse R (1990a) Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 66:1287–1293
Galle J, Lückhoff A, Busse R, Bassenge E (1990b) Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arteriosclerosis (in press)
Gardiner S, Compton A, Bennet T, Palmer R, Moncada S (1990) Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol 99: (in press)
Garthwaite J, Charles SL, Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385–388
Gavras H, Benetos A, Gavras I (1987) Contribution of bradykinin to maintenance of normal blood pressure. Hypertension 9 (Suppl III):III147–III149
Gebremedhin D, Koltei MZ, Pogatsa G, Magyer K, Hadhazy P (1988) Influence of experimental diabetes on the mechanical responses of canine coronary arteries: role of endothelium. Cardiovasc Res 22:537–544
Gerlach E, Deuticke B, Dreisbach RH (1963) Der Nucleotid-Abbau im Herzmuskel bei Sauerstoffmangel und seine mögliche Bedeutung für die Coronardurchblutung. Naturwissenschaften 6:228–229
Gerlings ED, Miller DT, Gilmore JP (1969) Oxygen availability: a determinant of myocardial potassium balance. Am J Physiol 216:559–562
Gerova M, Barta E, Gero J (1979a) Sympathetic control of major coronary artery diameter in the dog. Circ Res 44:459–467
Gerova M, Dolezel S, Gero J, Barta E (1979b) Role of the vagus in control of the major conduit coronary artery in the dog. Physiol Bohemoslov 28:299–307
Gerrity RG, Naito HK, Richardson M, Schwartz CJ (1979) Dietary induced atherogenesis in swine. Am J Pathol 95:775–792
Gewirtz H, Most AS, Williams DO (1982) The effect of generalized alpha-receptor stimulation on regional myocardial blood flow distal to a severe coronary artery stenosis. Circulation 65:1329–1336
Gewirtz H, Brautigan DL, Olsson RA, Brown P, Most AS (1983) Role of adenosine in the maintenance of coronary vasodilation distal to a severe coronary artery stenosis. Observations in conscious domestic swine. Circ Res 53:42–51
Gewirtz H, Weeks G, Nathanson M, Sharaf B, Fedele F, Most AS (1989) Tissue acidosis. Role in sustained arteriolar dilatation distal to a coronary stenosis. Circulation 79:890–898
Gibbs JSR, Crean PA, Mockus L, Wright C, Sutton GC, Fox KM (1989) The variable effect of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina. Br Heart J 62: 112–117
Gibson A, Mirzazadeh S, Hobbs AJ, Moore PK (1990) L-NG-monomethyl-arginine and L-NG-nitro-arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol 99:602–606
Ginsburg RC (1984) Myogenic tone of the isolated human epicardial artery: regulatory controls. Acta Med Scand 694[Suppl]:29–37
Ginsburg R, Bristow MR, Davis K, Billingham ME, Schroeder JS, Stinson EB, Harrison DC (1981) Receptor analysis of the human coronary artery — normal distribution and effect of atherosclerosis. Circulation 64 [Suppl
Glazier JJ, Faxon DP, Mills RM, Bresnahan MR, Ryan TJ, Gavras H (1989) Effect of arginine vasopressin on coronary and systemic hemodynamics in man. Int J Cardiol 24:95–103
Gorman MW, Sparks HV Jr (1982) Progressive coronary vasoconstriction during relative ischemia in canine myocardium. Circ Res 51:411–420
Gould L, Reddy GV, Gombrecht RF (1973) Oral phentolamine in angina pectoris. Jpn Heart J 14:393–397
Grant JA, Scrutton MC (1979) Novel a 2-adrenoceptors primarily responsible for inducing human platelet aggregation. Nature 277:659–661
Greenberg S, Diecke FPJ, Peevy K, Tanaka RP (1989) The endothelium modulated adrenergic neurotransmission to canine pulmonary arteries and veins. Eur J Pharmacol 162:67–80
Gregg DE (1963) Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 13:497–500
Griffith TM, Lewis MJ, Newby AC, Henderson AH (1988) Endothelium-derived relaxing factor. J Am Coll Cardiol 12:797–806
Gu J, Polak JM, Adrian TE, Allen JM, Tatemoto K, Bloom SR (1983) Neuropeptide tyrosine (NPY) — a major cardiac neuropeptide. Lancet I:1008–1010
Gunther S, Green L, Muller JE, Mudge GH, Grossman W (1981) Prevention by nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation 63:849–855
Guth BD, Heusch G, Seitelberger R, Ross Jr J (1987a) Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 60:738–746
Guth BD, Heusch G, Seitelberger R, Ross Jr J (1987b) Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 75:661–669
Guth BD, Thaulow E, Heusch G, Seitelberger R, Ross Jr J (1990) Myocardial effects of selective alpha-adrenoceptor blockade during exercise in dogs. Circ Res 66:1703–1712
Guz A, Kurland GS, Freedberg AS (1960) Relation of coronary flow to oxygen supply. Am J Physiol 199:179–182
Gwirtz PA, Stone HL (1982) Coronary blood flow changes following activation of adrenergic receptors in the conscious dog. Am J Physiol 243:H13–H19
Gwirtz PA, Overn SP, Mass HJ, Jones CE (1986) Alpha 1-adrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol 250:H1117–H1126
Haass M, Cheng B, Richardt G, Lang RE, Schömig A (1989) Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn Schmiedebergs Arch Pharmacol 339:71–78
Hackett JG, Abboud FM, Mark AL, Schmid PG, Heistad DD (1972) Coronary vascular responses to stimulation of chemoreceptors and baroreceptors. Circ Res 31:8–17
Haddy FJ, Scott JB (1975) Metabolic factors in peripheral circulatory regulation. Fed Proc 34:2006–2011
Hamilton FN, Feigl EO (1976) Coronary vascular sympathetic beta-receptor innervation. Am J Physiol 230:1569–1576
Han C, Abel PW (1987) Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries. J Cardiovasc Pharmacol 9:675–681
Harder DR (1987) Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 60:102–107
Harrison DG, Chilian WM, Marcus ML (1986) Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res 59:133–142
Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Heistad DD (1987a) Alterations of vascular reactivity in atherosclerosis. Circ Res 61 (Suppl II):II74–II80
Harrison DG, Armstrong ML, Freiman PC, Heistad DD (1987b) Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 80:1808–1811
Hart G, Gokal R (1977) The syndrome of inappropriate antidiuretic hormone secretion associated with acute myocardial infarction. Postgrad Med J 53:761–762
Hartmann A, Saeed M, Bing RJ (1987) Release of endothelium-derived relaxing factor from freshly harvested porcine endothelial cells. Circ Res 61:548–554
Hautamaa PV, Dai XZ, Homans DC, Robb JF, Bache RJ (1987) Vasomotor properties of immature canine coronary collateral circulation. Am J Physiol 252:H1105–H1111
Hautamaa PV, Dai X-Z, Homans DC, Bache RJ (1989) Vasomotor activity of moderately well-developed canine coronary collateral circulation. Am J Physiol 256:H890–H897
Haws CW, Green LS, Burgess MJ, Abildskov JA (1987) Effects of cardiac sympathetic nerve stimulation on regional coronary blood flow. Am J Physiol 252:H269–H274
Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL (1984) Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 54:711–718
Heistad DD, Mark AL, Marcus ML, Piegors DJ, Armstrong ML (1987) Dietary treatment of atherosclerosis abolishes hyperresponsiveness to serotonin: implications for vasospasm. Circ Res 61:346–351
Hennekens CH, Peto R, Hutchison GB, Doll R (1988) On overview of the British and American aspirin studies. N Engl J Med 318:923–924
Henry PD, Yokoyama M (1980) Supersensitivity of atherosclerotic rabbit aorta to ergonovine. J Clin Invest 66:306–313
Heusch G (1990) a-adrenergic mechanisms in myocardial ischemia. Circulation 81:1–13
Heusch G, Deussen A (1983) The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog. Circ Res 53:8–15
Heusch G, Deussen A (1984) Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol 6:378–383
Heusch G, Guth BD (1989) Neurogenic regulation of coronary vasomotor tone. Eur Heart J 10 (Suppl F):6–14
Heusch G, Yoshimoto N (1983a) Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion. Pfluegers Arch 397:284–289
Heusch G, Yoshimoto N (1983b) Effects of cardiac contraction on segmental coronary resistances and collateral perfusion. Int J Microcirc 2:131–141
Heusch G, Yoshimoto N, Heegemann H, Thämer V (1983) Interaction of methoxamine with compensatory vasodilation distal to coronary stenoses. Drug Res 33:1647–1650
Heusch G, Deussen A, Schipke J, Thämer V (1984) α1-and α2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 6:961–968
Heusch G, Deussen A, Schipke J, Thämer V (1986) Adenosine, dipyridamole and isosorbid-dinitrate are ineffective to prevent the sympathetic initiation of poststenotic myocardial ischemia. Drug Res 36:1045–1048
Heusch G, Seitelberger R, Guth BD, Ross Jr J (1986) Adrenergic mechanisms in myocardial ischemia. J Appl Cardiol 1:125–142
Heusch G, Guth BD, Seitelberger R, Ross Jr J (1987) Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation 75:482–490
Heyndrickx GR, Boettcher DH, Vatner SF (1976) Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 231:1579–1587
Heyndrickx GR, Muylaert P, Pannier JL (1982) α-adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol 242:H805–H809
Heyndrickx GR, Vilaine JP, Moerman EJ, Leusen I (1984) Role of prejunctional alpha 2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs. Circ Res 54:683–693
Hibbs JB, Vavrin Z, Taintor RR (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138:550–565
Hilton R, Eichholtz F (1925) The influence of chemical factors on the coronary circulation. J Physiol 59:413–425
Hirsch EF, Borghard-Erdle AM (1961) The innervation of the human heart. Arch Pathol 71:384–407
Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304:685–691
Hodgson JMcB, Marshall JJ (1989) Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 79:1043–1051
Hodgson JMcB, Cohen MD, Szentpetery S, Thames MD (1989) Effects of regional α-and β-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 79:797–809
Hoffman BB, Lefkowitz RJ (1980) Alpha-adrenergic receptor subtypes. N Engl J Med 302:1390–1396
Hoffman JIE (1987) Transmural myocardial perfusion. Prog Cardiovasc Dis 29:429–464
Holmgren S, Abrahamsson T, Almgren O (1985) Adrenergic innervation of coronary arteries and ventricular myocardium in the pig: fluorescence microscopic appearance in the normal state and after ischemia. Basic Res Cardiol 80:18–26
Holtz J, Grunewald WA, Manz R, von Restorff W, Bassenge E (1977a) Intracapillary hemoglobin oxygen saturation and oxygen consumption in different layers of the left ventricular myocardium. Pfluegers Arch 370:253–258
Holtz J, Mayer E, Bassenge E (1977b) Demonstration of alpha-adrenergic coronary control in different layers of canine myocardium by regional myocardial sympathectomy. Pfluegers Arch 372:187–194
Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptors. Eur J Pharmacol 82:199–202
Holtz J, Giesler M, Bassenge E (1983) Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. Z Kardiol 72 (Suppl 3):98–106
Holtz J, Förstermann U, Pohl U, Giesler M, Bassenge E (1984) Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects on cyclo-oxygenase inhibition. J Cardiovasc Pharmacol 6:1161–1169
Holtz J, Busse R, Sommer O, Bassenge E (1987) Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat. J Cardiovasc Pharmacol 9:348–355
Homcy CJ, Graham RM (1985) Molecular characterization of adrenergic receptors. Circ Res 56:635–650
Hopwood AM, Burnstock G (1987) ATP mediates coronary vasoconstriction via P2x-purinoceptors and coronary vasodilatation via P2y-purinoceptors in the isolated perfused rat heart. Eur J Pharmacol 136:49–54
Horio Y, Yasue H, Rokutanda M, Makamura N, Ogawa H, Takaoka K, Matsuyama K, Kimura T (1986) Effects of intracoronary injection of acetylcholine on coronary arterial diameter. Am J Cardiol 57:984–989
Hossack KF, Brown BG, Stewart DK, Dodge HT (1984) Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans. Circulation 70:465–471
Houston DS, Shepherd JT, Vanhoutte PM (1986) Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides. J Clin Invest 78:539–544
Howes LG, Krum H (1989) Plasma lipoproteins, cardiovascular reactivity and the sympathetic nervous system. J Auton Pharmacol 9:293–301
Huang AH, Feigl EO (1988) Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res 62:286–298
Igarashi Y, Aizawa Y, Tamura M, Ebe K, Yamaguchi T, Shibata A (1989) Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? Am Heart J 118:674–678
Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65:1–21
Ignarro LJ, Byrns RE, Buga GM, Wood KS (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61:866–879
Inoue T, Tomoike H, Hisano K, Nakamura M (1988) Endothelium determines flow-dependent dilation of the epicardial coronary artery in dogs. J Am Coll Cardiol 11:187–191
Ito BR, Feigl EO (1985a) Carotid baroreceptor reflex coronary vasodilation in the dog. Circ Res 56:486–495
Ito BR, Feigl EO (1985b) Carotid chemoreceptor reflex parasympathetic coronary vasodilation in the dog. Am J Physiol 249:H1167–H1175
Jacobs M, Plane F, Bruckdorfer KR (1990) Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 100:21–26
Jie K, van Brummelen P, Vermey P, Timmermans PBMWM, van Zwieten PA (1984) Identification of vascular postsynaptic α1-and α2-adrenoceptors in man. Circ Res 54:447–452
Jie K, van Brummelen P, Vermey P, Timmermans PBMWM, van Zwieten PA (1987) Postsynaptic alpha 1-and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines. Eur J Clin Invest 17:174–181
Johannsen UJ, Mark AL, Marcus ML (1982) Responsiveness to cardiac sympathetic nerve stimulation during maximal coronary dilation produced by adenosine. Circ Res 50:510–517
Johansson B, Mellander S (1975) Static and dynamic components in the vascular myogenic response to passive changes in length as revealed by electrical and mechanical recordings from the rat portal vein. Circ Res 36:76–83
Johnson JR, Di Palma JR (1939) Intramyocardial pressure and its relation to aortic blood pressure. Am J Physiol 125:234–243
Jones CE, Liang IYS, Maulsby MR (1986) Cardiac and coronary effects of prazosin and phenoxybenzamine during coronary hypotension. J Pharmacol Exp Ther 236:204–211
Jugdutt BI (1981) Effects of prostacyclin, prostaglandin E 1 and E 2 on spontaneous ventricular arrhythmias in infarction. Circulation 64 (Suppl IV):IV-319 (abstract)
Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC (1980) Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog. Am J Cardiol 46:74–82
Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC (1981) Dissimilar effects of prostacyclin, prostaglandin E 1 and prostaglandin E 2 on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res 49:685–700
Kalsner S (1985) Cholinergic mechanisms in human coronary artery preparations: Implications of species differences. J Physiol 358:509–526
Kamiya A, Togawa T (1980) Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 239:H14–H21
Kanatsuka H, Lamping KG, Eastham CL, Marcus ML (1990) Heterogenous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 66:389–396
Kasuya Y, Takuwa Y, Yanagisawa M, Kimura S, Goto K, Masaki T (1989) Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. Biochem Biophys Res Comm 161:1049–1055
Katori M, Berne RM (1966) Release of adenosine from anoxic hearts. Relationship to coronary flow. Circ Res 19:420–425
Kelley KO, Feigl EO (1978) Segmental alpha-receptor-mediated vasoconstriction in the canine coronary circulation. Circ Res 43:908–917
Kelm M, Schrader J (1988) Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 155:317–321
Khayyal MA, Eng C, Franzen D, Breall JA, Kirk ES (1985) Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am J Physiol 248:H516–H522
Kjekshus JK (1973) Mechanisms for flow distribution in normal and ischemic myocardium during increased ventricular preload in the dog. Circ Res 33:489–499
Klocke FJ (1987) Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation 76:1183–1189
Klocke FJ, Kaiser GA, Ross Jr J, Braunwald E (1965) An intrinsic adrenergic vasodilator mechanism in the coronary vascular bed of the dog. Circ Res 16:376–382
Klocke FJ, Weinstein IR, Klocke JF, Ellis AK, Kraus DR, Mates RE, Canty JM, Anbar RD, Romanowski RR, Wallmeyer KW, Echt MP (1981) Zero-flow pressures and pressure-flow relationships during single long diastoles in the canine coronary bed before and during maximum vasodilation. J Clin Invest 68:970–980
Knabb RM, Ely SW, Bacchus AN, Rubio R, Berne RM (1983) Consistent parallel relationships among myocardial oxygen consumption, coronary blood flow, and pericardial infusate adenosine concentration with various interventions and β-blockade in the dog. Circ Res 53:33–41
Knowles RG, Palacios M, Palmer RMJ, Moncada S (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 86:5159–5162
Kobinger W, Pichler L (1980) Investigation into different types of post-and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402
Kobinger W, Pichler L (1981) α1-and α2-adrenoceptor subtypes: selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol 73:313–321
Kodama M, Kanaide H, Abe S, Hirano K, Kai H, Nakamura M (1989) Endothelin-induced Ca-independent contraction of the porcine coronary artery. Biochem Biophys Res Comm 160:1302–1308
Koltai MZ, Rösen P, Hadhazy P, Ballagi-Pordany G, Köszeghy A, Pogatsa G (1988) Relationship between vascular adrenergic receptors and prostaglandin biosynthesis in canine diabetic coronary arteries. Diabetologia 31: 681–686
Kopia GA, Kopaciewicz LJ, Ruffolo Jr RR (1986) Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries. J Pharmacol Exp Ther 239:641–647
Koster PF, Ohlstein EH, Nichols AJ (1989) The effect of intracoronary endothelin on coronary hemodynamics and cardiac function in anesthetized dogs. Faseb J 3:A878 (abstract)
Kreuzer H, Schoeppe W (1963) Das Verhalten des Druckes in der Herzwand. Pfluegers Arch 278:181–198
Kroll K, Feigl EO (1985) Adenosine is unimportant in controlling coronary blood flow in unstressed dog hearts. Am J Physiol 249:H1176–H1187
Kroll K, Schrader J, Piper HM, Henrich M (1987) Release of adenosine and cyclic AMP from coronary endothelium in isolated guinea pig hearts: relation to coronary flow. Circ Res 60:659–665
Ku DD (1989) Endothelin produces potent vasoconstriction in isolated human coronary arteries, veins and long-term coronary aortic bypass grafts. Circulation 80 (Suppl II):II-213 (abstract)
Kulakowski EC, Lampson WG, Schaffer SW, Lovenberg W (1983) Action of substance P on the working rat heart. Biochem Pharmacol 32:1097–1100
Kumpuris AG, Luchi RJ, Waddell CC, Miller RR (1980) Production of circulating platelet aggregates by exercise in coronary patients. Circulation 61:62–65
Kuo L, Chilian WM, Davis MJ (1990) Coronary arteriolar myogenic response is independent of endothelium. Circ Res 66:860–866
Kurihara H, Yamaoki K, Nagai R, Yoshizumi M, Takaku F, Satoh H, Inui J, Yazaki Y (1989) Endothelin — a potent vasoconstrictor associated with coronary vasospasm. Life Sci 44:1937–1943
Kuzuya T, Tada M, Ohmori M, Inui M, Abe H, Yamagishi M, Kodama K (1981) Altered metabolism of thromboxane A2 and prostaglandin I2 in patients with angina pectoris. Circulation 64 (Suppl IV):IV-143 (abstract)
Lam LYT, Chesebro JH, Steele PM, Badimon L, Fuster V (1987) Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 75:243–248
Lamping KG, Dole WP (1987) Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res 61:904–913
Lamping KG, Eastham CL (1989) Endothelin: a potent vasoconstrictor in the coronary microcirculation. Circulation 80 (Suppl II):II-212 (abstract)
Lamping KG, Kanatsuka H, Eastham CL, Chilian WM, Marcus ML (1989) Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin. Circ Res 65:343–351
Langer GA, Brady AJ (1966) Potassium in dog ventricular muscle: kinetic studies of distribution and effects of varying frequency of contraction and potassium concentration of perfusate. Circ Res 18:164–177
Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362
Langer SZ, Adler-Graschinsky E, Giorgi O (1977) Physiological significance of α-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation. Nature 265:648–650
Langille BL, O'Donnel F (1986) Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231:405–407
Lansman JB, Hallam TJ, Rink TJ (1987) Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325:811–813
Larkin SW, Clarke JG, Koegh BE, Araujo L, Rhodes C, Davies GJ, Taylor KM, Maseri A (1989) Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 64:956–958
Laxson DD, Dai X-Z, Homans DC, Bache RJ (1989) The role of α1-and α2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res 65:1688–1697
Levene DL, Freeman MR (1976) α-adrenoceptor-mediated coronary artery spasm. J Am Med Assoc 236:1018–1022
Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, Le Winter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, De Mots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a veterans administration cooperative study. N Engl J Med 309:396–403
Liang C-S, Gavras H, Black J, Sherman LG, Hood Jr WB (1982) Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Circulation 66:1249–1255
Liang IYS, Jones CE (1985) Alpha 1-adrenergic blockade increases coronary blood flow during coronary hypoperfusion. Am J Physiol 249:H1070–H1077
Linder C, Heusch G (1990) ACE-inhibitors for the treatment of myocardial ischemia? Cardiovasc Drugs Ther (in press)
Linder L, Kiowski W, Bühler FR, Lüscher TF (1990) Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation 81:1762–1767
Liu JJ, Chen DJ, Casley DJ, Nayler WG (1990a) Effect of ischaemia and reperfusion on 125I endothelin binding in rat cardiac membranes. Am J Physiol 258:H829–H835
Lochner W, Nasseri M (1959) Über den venösen Sauerstoffdruck, die Einstellung der Coronardurchblutung und den Kohlenhydratstoffwechsel des Herzens bei Muskelarbeit. Pfluegers Arch 269:407–416
Lopez JAG, Armstrong ML, Piegors DJ, Heistad DD (1989) Effect of early and advanced atherosclerosis on vascular responses to serotonin, thromboxane A2, and ADP. Circulation 79:698–705
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxial vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046–1051
Lückhoff A, Busse R (1990) Calcium influx into endothelial cells and formation of EDRF is controlled by the membrane potential. Pfluegers Arch 416:305–311
Lüscher TF, Vanhoutte PM (1986) Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344–348
Lüscher TF, Rau L, Vanhoutte PM (1987) Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9:157–163
Marcus ML, Wright C, Doty D, Eastham C, Laughlin D, Krumm P, Fastenow C, Brody M (1981) Measurements of coronary velocity and reactive hyperemia in the coronary circulation of humans. Circ Res 49:877–891
Margolius HS (1989) Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Annu Rev Pharmacol Toxicol 29:343–364
Mark AL, Abboud FM, Schmid PG, Heistad DD, Mayer UJ (1972) Differences in direct effects of adrenergic stimuli on coronary, cutaneous and muscular vessels. J Clin Invest 51:279–287
Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706–8711
Marsden PA, Danthuluri NR, Brenner BM, Ballermann BJ, Brock TA (1989) Endothelin action on vascular smooth muscle involves inositol triphosphate and calcium mobilization. Biochem Biophys Res Comm 158:86–93
Martin SE, Patterson RE (1989) Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers. Am J Physiol 257:H927–H934
Maruoka Y, McKirnan MD, Engler RL, Longhurst JC (1987) Functional significance of alpha-adrenergic receptors in mature coronary collateral circulation of dogs. Am J Physiol 253:H582–H590
Mates RE, Klocke FJ, Canty JM (1988) Coronary capacitance. Prog Cardiovasc Dis 31:1–15
Matsuda H, Kuon E, Holtz J, Busse R (1985) Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha 2-adrenergic agonists. J Cardiovasc Pharmacol 7:680–688
Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross Jr J (1984) Effects of β-blockade on regional myocardial flow and function during exercise. Am J Physiol 247:H52–H60
McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochem J 261:293–296
McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, MacIntyre I, Maseri A (1986) Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation 74:1243–1247
McGrath JC (1982) Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31:467–484
McHale PA, Dube GP, Greenfield Jr JC (1987) Evidence for myogenic vasomotor activity in the coronary circulation. Prog Cardiovasc Dis 30:139–146
McRaven DR, Mark AL, Abboud FM, Mayer HE (1971) Responses of coronary vessels to adrenergic stimuli. J Clin Invest 50:773–778
Melkumyants AM, Balashov SA, Veselova ES, Khayutin VM (1987) Continuous control of the lumen of feline conduit arteries by blood flow rate. Cardiovasc Res 21:863–870
Melkumyants AM, Balashov SA, Khayutin VM (1989) Endothelium dependent control of arterial diameter by blood viscosity. Cardiovasc Res 23:741–747
Mellander S, Johansson B (1968) Control of resistance, exchange, and capacitance functions in the peripheral circulation. Pharmacol Rev 20:117–196
Mellander S, Johansson B, Gray S, Jonsson O, Lundvall J, Ljung B (1967) The effects of hyperosmolarity on intact and isolated vascular smooth muscle. Possible role in exercise hyperemia. Angiologica 4:310–322
Miller WL, Belardinelli L, Bacchus A, Foley DH, Rubio R, Berne RM (1979) Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation. Circ Res 45:708–718
Miwa K, Kambara H, Kawai C (1981) Exercise-induced angina evoked by aspirin administration in patients with variant angina. Am J Cardiol 47:1210–1214
Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T (1989) Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet II:53–54
Mohrman DE, Feigl EO (1978) Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42:79–86
Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Moncada S, Palmer RMJ, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709–1715
Monos E, Cox RH, Peterson LH (1978) Direct effect of physiological doses of arginine vasopressin on the arterial wall in vivo. Am J Physiol 234:H167–H172
Mosher P, Ross Jr J, McFate PA, Shaw RF (1964) Control of coronary blood flow by an autoregulatory mechanism. Circ Res 14:250–259
Motulsky HJ, Snavely MD, Hughes RJ, Insel PA (1983) Interaction of verapamil and other calcium channel blockers with α1-and α2-adrenergic receptors. Circ Res 52:226–231
Motulsky HJ, Maisel AS, Snavely MD, Insel PA (1984) Quinidine is a competitive antagonist at alpha 1-and alpha 2-adrenergic receptors. Circ Res 55:376–381
Mudge GH, Grossman W, Mills Jr RM, Lesch M, Braunwald E (1976) Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 295:1333–1337
Mudge GH, Goldberg S, Gunther S, Mann T, Grossman W (1979) Comparison of metabolic and vasoconstrictor stimuli on coronary vascular resistance in man. Circulation 59:544–550
Mueller HS, Rao PS, Rao PB, Gory DJ, Mudd JG, Ayres SM (1982) Enhanced transcardiac 1-norepinephrine response during cold pressor test in obstructive coronary artery disease. Am J Cardiol 50:1223–1228
Mülsch A, Bassenge E, Busse R (1989) Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedebergs Arch Pharmacol 340:767–770
Mülsch A, Busse R (1990) NG-nitro-L-arginine (N5-[imino (nitroamino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol 341:143–147
Münzel T, Stewart DJ, Holtz J, Bassenge E (1988) Preferential venoconstriction by cyclooxygenase inhibition in vivo without attenuation of nitroglycerin venodilation. Circulation 78:407–415
Murphree SS, Saffitz JE (1988) Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 63:117–125
Murray PA, Vatner SF (1979) α-adrenoceptor attenuation of coronary vascular response to severe exercise in the conscious dog. Circ Res 45:654–660
Murray PA, Belloni FL, Sparks HV (1979) The role of potassium in the metabolic control of coronary vascular resistance of the dog. Circ Res 44:767–780
Murray PA, Lavallee M, Vatner SF (1984) Alpha-adrenergic-mediated reduction in coronary blood flow secondary to carotid chemoreceptor reflex activation in conscious dogs. Circ Res 54:96–106
Mustard JF, Kinlough-Rathbone RL, Packham MA (1983) Aspirin in the treatment of cardiovascular disease: a review. Am J Med 74 (Suppl A6):43–49
Myers PR, Banitt PF, Guerra R, Harrison DG (1989) Characteristics of canine coronary resistance arteries: importance of endothelium. Am J Physiol 257:H603–H610
Myers P, Minor R, Guarra R, Bates J, Harrison D (1990) Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: (in press)
Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP (1988a) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77:43–52
Nabel EG, Ganz P, Selwyn AP (1988b) Atherosclerosis impairs flow-mediated dilation in human coronary arteries. Circulation 78 (Suppl II):II-474 (abstract)
Nagasawa K, Tomoike H, Hayashi Y, Yamada A, Yamamoto T, Nakamura M (1989) Intramural hemorrhage and endothelial changes in atherosclerotic coronary artery after repetitive episodes of spasm in x-ray-irradiated hypercholesterolemic pigs. Circ Res 65:272–282
Nagata M, Pichet R, Lavallee M (1988) Coronary dilation with carotid chemoreceptor stimulation in cardiac-denervated dogs. Am J Physiol 255:H1330–1335
Nakane T, Chiba S (1987) Postjunctional α-adrenoceptor subtypes in isolated and perfused canine epicardial coronary arteries. J Cardiovasc Pharmacol 10:651–657
Nakane T, Tsujimoto G, Hashimoto K, Chiba S (1988) Beta adrenoceptors in the canine large coronary arteries: beta-1 adrenoceptors predominate in vasodilation. J Pharmacol Exp Ther 245:936–943
Nakao K, Saito Y, Matsuyama K, Okumura K, Jougasaki M, Yasue H (1989) Implication of endothelin in variant angina. Circulation 80 (Suppl II):II-586 (abstract)
Nathan HJ, Feigl EO (1986) Adrenergic vasoconstriction lessens transmural steal during coronary hypoperfusion. Am J Physiol 250:H645–H653
Nellessen U, Lee TC, Fischell TA, Ginsburg R, Masuyama T, Alderman EL, Schroeder JS (1988) Effects of acetylcholine on epicardial coronary arteries after cardiac transplantation without angiographic evidence of fixed graft narrowing. Am J Cardiol 62:1092–1097
Nichols WW, Mehta JL, Thompson L, Donnelly WH (1988) Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Am J Physiol 255:H153–H159
Nicod P, Winniford MD, Campbell WB, Rehr RB, Firth BG, Hillis LD (1984) Alterations in coronary blood flow induced by cigarette smoking: Lack of relation to plasma arginine vasopressin concentrations. Am J Cardiol 54:667–668
Olesen S-P, Clapham DE, Davies PF (1988) Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331:168–170
Olsson RA, Bünger R (1987) Metabolic control of coronary blood flow. Prod Cardiovasc Dis 29:369–387
Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC (1978) Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest 62:459–467
Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM (1989a) Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol 256:C591–C597
Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM (1989b) Cardiovascular effects of acute hypercholesterolemia in in rabbits. J Clin Invest 83:465–473
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Pantely GA, Bristow JD, Swenson LJ, Ladley HD, Johnson WB, Anselone CG (1985a) Incomplete coronary vasodilation during myocardial ischemia in swine. Am J Physiol 249:H638–H647
Pantely GA, Ladley HD, Anselone CG, Bristow JD (1985b) Vasopressin-induced coronary constriction at low perfusion pressures. Cardiovasc Res 19:433–441
Panzenbeck MJ, Kaley G (1983) Leukotriene D4 reduces coronary blood flow in the anesthetized dog. Prostaglandins 25:661–670
Peters KG, Marcus ML, Harrison DG (1989) Vasopressin and the mature coronary collateral circulation. Circulation 79:1324–1331
Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72:406–412
Pitt B, Sugishita Y, Gregg DE (1969a) Coronary hemodynamic effects of calcium in the unanesthetized dog. Am J Physiol 216:1456–1459
Pitt B, Mason J, Conti CR, Colman RW (1969b) Activation of the plasma kallikrein during myocardial ischemia. Pharmacol Res Comm 1:185–186
Pitt B, Pasyk S, Walton J, Grekin R (1982) tEndogenous arginine vasopressin release in patients with coronary artery spasm. Circulation 66 (Suppl II):II-88 (abstract)
Pitt B, Shea MJ, Romson JL, Lucchesi BR (1983) Prostaglandins and prostaglandin inhibitors in ischemic heart disease. Ann Intern Med 99:83–92
Pohl U, Busse R (1988) Reduced nutritional blood flow in autoperfused rabbit hindlimbs following inhibition of endothelial vasomotor function. In: Halpern W, Pegram B, Brayden J, Mackey K, McLaughlin M, Osol G (eds) Resistance arteries. Perinatology Press, Ithaca, NY, pp 10–16
Pohl U, Busse R (1989a) EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res 65:1798–1803
Pohl U, Busse R (1989b) Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol 256:H1595–H1600
Pohl U, Busse R (1989c) Differential vascular sensitivity to luminally and adventitially applied endothelin-1. J Cardiovasc Pharmacol 13 [Suppl 5]:S188–S190
Pohl U, Holtz J, Busse R, Bassenge E (1986a) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8:37–44
Pohl U, Busse R, Kuon E, Bassenge E (1986b) Pulsatile perfusion stimulates the release of endothelial autacoids. J Appl Cardiol 1:215–235
Pohl U, Herlan K, Huang A, Bassenge E (1990a) EDRF-mediated, shear-induced dilation opposes myogenic vasoconstriction. Am J Physiol (in press)
Pohl U, Lamontagne D, Bassenge E, Busse R (1990b) EDRF augments coronary conductivity through attenuation of myogenic autoregulation. Pflügers Arch 414 Suppl 1:R 62 (abstract)
Quadt JFA, Voss R, TenHoor F (1982) Prostacyclin production of the isolated pulsatingly perfused rat aorta. J Pharmacol Method 7:263–270
Raberger G, Weissel M, Kraupp O (1971) The dependence of the effects of i. cor. administered adenosine and of coronary conductance on the arterial pH, pCO2 and buffer capacity in dogs. Nauny Schmiedebergs Arch Pharmacol 271:301–310
Radomski MW, Palmer RMJ, Moncada S (1987a) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Comm 148:1482–1489
Radomski MW, Palmer RMJ, Moncada S (1987b) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181–187
Radomski MW, Palmer RMJ, Moncada S (1987c) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639–646
Raff WK, Lochner W (1974) Wirkungsmechanismus von Nitroglycerin. Med Klin 69:1100–1104
Raff WK, Kosche F, Lochner W (1971a) Herzfrequenz und extravasale Komponente des Coronarwiderstandes. Pfluegers Arch 323:241–249
Raff WK, Kosche F, Lochner W (1971b) Extravasale Komponente des Coronarwiderstandes und Coronardurchblutung bei steigendem enddiastolischen Druck. Pfluegers Arch 327:225–233
Raff WK, Kosche F, Lochner W (1971c) Die extravasale Komponente des Coronarwiderstandes bei Steigerung der linksventrikulären Druckanstiegsgeschwindigkeit durch Isoproterenol. Pfluegers Arch 325:323–333
Raff WK, Kosche F, Lochner W (1972a) Extravascular coronary resistance and its relation to microcirculation. Am J Cardiol 29:598–603
Raff WK, Kosche F, Goebel H, Lochner W (1972b) Coronary extravascular resistance at increasing left ventricular pressure. Pfluegers Arch 333:352–361
Rafflenbeul W, Bassenge E, Lichtlen PR (1988) Competition between endothelium-and nitroglycerin-induced coronary vasodilation. Circulation 78 (Suppl II):II-455 (abstract)
Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ (1980) Provocation of coronary artery spasm by the cold pressor test. Circulation 62:925–932
Rees DD, Palmer RM, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375–3378
Reid JVO, Ito BR, Huang AH, Buffington CW, Feigl EO (1985) Parasympathetic control of transmural coronary blood flow in dogs. Am J Physiol 249:H337–H343
Richardt G, Waas W, Kranzhöfer R, Mayer E, Schömig A (1987) Adenosine inhibits exocytotic release of endogeneous noradrenaline in the rat heart: A protective mechanism in early myocardial ischemia. Circ Res 61:117–123
Richardt G, Waas W, Kranzhöfer R, Cheng B, Lohse MJ, Schömig A (1989) Interaction between the release of adenosine and noradrenaline during sympathetic stimulation: A feedback mechanism in rat heart. J Mol Cell Cardiol 21:269–277
Rimele TJ, Rooke TW, Aarhus LL, Vanhoutte PM (1983) Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries. J Pharmacol Exp Ther 226:668–672
Rinkema LE, Thomas Jr JX, Randall WC (1982) Regional coronary vasoconstriction in response to stimulation of stellate ganglia. Am J Physiol 243:H410–H415
Robertson RM, Robertson D, Roberts LJ, Maas RL, FitzGerald GA, Friesinger GC, Oates JA (1981) Thromboxane A2 in vasotonic angina pectoris. Evidence from direct measurements and inhibitor trials. N Engl J Med 304:998–1003
Robertson RM, Bernard YD, Carr RK, Robertson D (1983) Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha-receptor blockade with prazosin. J Am Coll Cardiol 2:1146–1150
Rodbard S (1975) Vascular caliber. Cardiology 60:4–49
Rosendorff C, Hoffman JIE, Verrier ED, Rouleau J, Boerboom LE (1981) Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res 48:320–329
Ross J, Klocke FJ, Kaiser G, Braunwald E (1963) Effect of alterations of coronary blood flow on the oxygen consumption of the working heart. Circ Res 13:510–513
Rouleau J, Boerboom LE, Surjadhana A, Hoffman JIE (1979) The role of autoregulation and tissue diastolic pressures in the transmural distribution of left ventricular blood flow in anesthetized dogs. Circ Res 45:804–815
Rousseau MF, Close P, Pouleur H (1989) Are the angiotensin-converting enzyme inhibitors poor anti-ischemic drugs? Circulation 80 (Suppl II):II-52 (abstract)
Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145–H1149
Rudehill A, Sollevi A, Franco-Cereceda A, Lundberg JM (1986) Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects. Peptides 7:821–826
Ruffolo RR, Sulpizio AC, Nichols AJ, DeMarinis RM, Hieble JP (1987) Pharmacologic differentiation between pre-and postjunctional alpha 2-adrenoceptors by SKandF 104078. Naunyn Schmiedebergs Arch Pharmacol 336:415–418
Sabbah HN, Stein PD (1982) Effect of acute regional ischemia on pressure in the subepicardium and subendocardium. Am J Physiol 242:H240–H244
Sabiston DC, Gregg DE (1957) Effect of cardiac on coronary blood flow. Circulation 15:14–20
Saeed M, Sommer O, Holtz J, Bassenge E (1982) α-adrenoceptor blockade by phentolamine causes β-adrenergic vasodilation by increased catecholamine release due to presynaptic α-blockade. J Cardiovasc Pharmacol 4:44–52
Saeed M, Holtz J, Elsner D, Bassenge E (1985) Sympathetic control of myocardial oxygen balance in dogs mediated by activation of coronary vascular α2-adrenoceptors. J Cardiovasc Pharmacol 7:167–173
Saito D, Steinhart CR, Nixon DG, Olsson RA (1981) Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ Res 49:1262–1267
Sakuma I, Togashi H, Yoshioka M, Kobayashi T, Saito H, Yasuda H, Gross S, Levi R (1990) Effects of intracisternal and intracisternal administration of L-NG-monomethyl arginine on renal sympathetic nerve activity in anesthetized rats. In: Moncada S, Higgs EA (eds) Nitric oxide from L-arginine, a bioregulatory system. Elsevier, Amsterdam pp 481–482
Salminen K, Tikkanen I, Saijonmaa O, Nieminen M, Fyhrquist F, Frick MH (1989) Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet II:747
Schipke J, Heusch G, Deussen A, Thaemer V (1985) Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Drug Res 35:926–929
Schipke J, Heusch G, Thämer V (1987) Evidence against the adenosine catecholamine antagonism in the canine heart in situ. Drug Res 37:1345–1347
Schmid PG, Wendling MG, Mark AL, Eckstein JW, Abboud FM (1970) Coronary vascular response to physiological levels of vasopressin. Circulation 41/42 (Suppl III):III-196 (abstract)
Schmid PG, Abboud FM, Wendling MG, Ramberg ES, Mark AL, Heistad DD, Eckstein JW (1974) Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am J Physiol 227:998–1004
Schmitz JM, Apprill PG, Buja M, Willerson JT, Campbell WB (1985) Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res 57:223–231
Schrader J (1981) Sites of action and production of adenosine in the heart. In: Burnstock G (ed) Purinergic receptors. Chapman and Hall, London, pp 121–162
Schrader J, Deussen A (1988) Free cytosolic adenosine sensitivity signals myocardial hypoxia. In: Acker H (ed) Oxygen sensing in tissue. Springer Berlin Heidelberg New York, pp 165–176
Schrader J, Gerlach E (1976) Compartmentation of cardiac adenine nucleotides and formation of adenosine. Pfluegers Arch 367:129–135
Schrader J, Rubio R, Berne RM (1975) Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca-influx. J Mol Cell Cardiol 7:427–433
Schrader J, Baumann G, Gerlach E (1977) Antiadrenergic action of adenosine in the heart: possible physiological significance. Pfluegers Arch 372:29–35
Schrör K (1990) Thromboxane A2 and platelets as mediators of coronary arterial vasoconstriction in myocardial ischemia. Eur Heart J 11 (Suppl B):27–34
Schrör K, Ahland B, Weiss P, König E (1988) Stimulation of coronary vascular PGI2 by organic nitrates. Eur Heart J 9 (Suppl A):25–32
Schulz R, Heusch G, Oudiz R, Guth BD (1989) Coronary pressure and flow have no independent effect on contractility in anesthetized swine. Faseb J 3:A405 (abstract)
Schulz R, Oudiz RJ, Guth BD, Heusch G (1990) Minimal α1-and α2-adrenoceptor mediated coronary vasconstriction in the anaesthetized swine. Naunyn Schmiedebergs Arch 342:422–428
Schumacher WA, Heran CL, Goldenberg HJ, Harris DN, Ogletree ML (1989) Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys. Am J Physiol 256:H726–H734
Schwartz GG, McHale PA, Greenfield JC (1982) Hyperemic response of the coronary circulation to brief diastolic occlusion in the conscious dog. Circ Res 50:28–37
Schwartz JS, Carlyle PF, Cohn JN (1980) Effect of coronary arterial pressure on coronary stenosis resistance. Circulation 61:70–76
Schwartz PJ, Stone HL (1977) Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res 41:51–58
Scott JB, Radawski D (1971) Role of hyperosmolarity in the genesis of active and reactive hyperemia. Circ Res 28 (Suppl I):I26–I32
Seitelberger R, Schütz W, Schlappack O, Raberger G (1984) Evidence against the adenosine-catecholamine antagonism under in vivo conditions. Naunyn Schmiedebergs Arch 325:234–239
Seitelberger R, Guth BD, Lee JD, Katayama K, Heusch G, Ross Jr J (1986) Alpha 1 and alpha 2 receptor stimulation in conscious dogs increase coronary resistance but not myocardial function. J Am Coll Cardiol 7 (Suppl A):81A (abstract)
Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, Ross Jr J (1988) Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62:436–442
Shimokawa H, Flavahan NA, Vanhoutte PM (1989a) Natural course of the impairment of endothelium-dependent relaxation after balloon endothelium removal in procine coronary arteries: possible dysfunction of a pertussis-sensitive G protein. Circ Res 65:740–753
Shimokawa H, Flavahan NA, Sheperd JT, Vanhoutte PM (1989b) Endothelium-dependent inhibition of ergonovine-induced contraction is impaired in procine coronary arteries with regenerated endothelium. Circulation 80:643–650
Siegel G, Schneider W (1981) Anions, cations, membrane potential and relaxation. In: Vanhoutte PM, Leusen I (eds) Vasodilatation. Raven, New York, pp 285–305
Silberbauer K, Slany J, Sinzinger H, Punzengruber C (1982) Molsidomin, Koronartherapeutikum mit plättchenaggregationshemmender Wirkung. Z Kardiol 71:539–543
Simmet T, Peskar BA (1986) Eicosanoids and the coronary circulation. Rev Physiol Biochem Pharmacol 104:1–64
Simon BC, Cunningham LD, Cohen RA (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in pig coronary artery. J Clin Invest 86:75–79
Sink JC, Hill RC, Chitwood Jr WR, Abriss R, Wechsler AS (1979) Effects of phenylephrine on transmural distribution of myocardial blood flow in regions supplied by normal and collateral arteries during cardiopulmonary bypass. J Thorac Cardiovasc Surg 78:236–243
Smiesko V, Kozik J, Dolezel S (1985) Role of endothelium in the control of arterial diameter by blood flow. Blood Vessels 22:247–251
Smith JB, Araki H, Lefer AM (1980) Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation 62 (Suppl V):V19–V25
Smitherman TC, Popma JJ, Said SI, Krejs GJ, Dehmer GJ (1989) Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans. Am J Physiol 257:H1254–H1262
Spaan JAE, Breuls NPW, Laird JD (1981) Diastolic-systolic coronary flow differences are caused by intramyocardial pump action in anesthetized dog. Circ Res 49:584–593
Starke K (1981) Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–235
Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 321:129–135
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924
Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883–3887
Stephenson JA, Gibson RE, Summers RJ (1988) An autoradiographic study of muscarinic cholinoceptors in blood vessels: no localization on vascular endothelium. Eur J Pharmacol 153:271–283
Stewart DJ, Holtz J, Pohl U, Bassenge E (1987a) Balance between endothelium-mediated dilating and direct constricting actions of serotonin on resistance vessels in the isolated rabbit heart. Eur J Pharmacol 143:131–134
Stewart DJ, Münzel T, Bassenge E (1987b) Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin. Eur J Pharmacol 136:239–242
Strader JR, Gwirtz PA, Jones CE (1988) Comparative effects of α1-and α2-adrenoceptors in modulation of coronary flow during exercise. J Pharmacol Exp Ther 246:772–778
Sugiura M, Inagami T, Kon V (1989) Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Comm 161:1220–1227
Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Mikami H, Ogihara T (1989) Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery. Biochem Biophys Res Comm 161:803–808
Tesfamariam B, Cohen RA (1988) Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ Res 63:720–725
Tesfamariam B, Weisbrod RM, Cohen RA (1987) Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation. Am J Physiol 253:H792–H798
Thaulow E, Guth BD, Schulz R, Ross Jr J (1989) Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischemia in dogs. Acta Physiol Scand 136:321–330
Thiemermann C, Smith III EF, Schrör K (1986) Successful treatment of acute myocardial ischemia with teopranitol — a novel organic nitrate. Eur Heart J 7:418–424
Tillmanns H, Ikeda S, Hansen H, Sarma JSM, Fauvel J-M, Bing RJ (1974) Microcirculation in the ventricle of the dog and turtle. Circ Res 34:561–569
Toda N (1986) Alpha-adrenoceptor subtypes and diltiazem actions in isolated human coronary arteries. Am J Physiol 250:H718–H724
Tomoike H, Egashira K, Yamamoto Y, Nakamura M (1989) Enhanced responsiveness of smooth muscle, impaired endothelium-dependent relaxation and the genesis of coronary spasm. Am J Cardiol 63:33E–39E
Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Yanagisawa M, Masaki T (1989) Contribution of endothelin (ET) and atrial natriuretic factor (ANF) to coronary spasm in patients with vasospastic angina. Circulation 80 (Suppl II):II-126 (abstract)
Tzivoni D, Keren A, Benhorin J, Gottlieb S, Atlas D, Stern S (1983) Prazosin therapy for refractory variant angina. Am Heart J 105:262–266
Uchida Y, Murao S (1974) Cyclic changes in peripheral blood pressure of partially constricted coronary artery. Jpn Coll Angiol 14:383–393
Van Gilst WH, van Wijngaarden J, Scholtens E, de Graeff PA, de Langen CDJ, Wesseling H (1987) Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism? J Cardiovasc Pharmacol 9 (Suppl 2):S31–S36
Van Gilst WH, Tio RA, de Graeff PA, van Wijngaarden J, Scholtens E, de Langen CDJ, Wesseling H (1989) Antiischämische Wirkungen von Conversions-Enzym-Hemmern. Muench Med Wschr 131 (Suppl 1):S27–S30
Vanhoutte PM (1987) Endothelium and the control of vascular tissue. News Pharmacol Sci 2:18–22
Vanhoutte PM (1988) The endothelium and control of coronary arterial tone. Hosp Pract 77–94
Vanhoutte PM, Houston DS (1985) Platelets, endothelium, and vasospasm. Circulation 72:728–734
Vanhoutte PM, Katusic ZS, Shepherd JT (1984) Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertension 2 (Suppl 3):421–422
Van Meel JCA, de Jonge A, Timmermans PBMWM, van Zwieten PA (1981) Selectivity of some alpha adrenoceptor agonists for peripherial alpha1-and alpha2-adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 219:760–767
Van Winkle DM, Feigl EO (1989) Acetylcholine causes coronary vasodilation in dogs and baboons. Circ Res 65:1580–1593
Van Zwieten PA, Timmermans PBMWM (1983) Cardiovascular α2-receptors. J Mol Cell Cardiol 15:717–733
Vatner DE, Knight DR, Homcy CJ, Vatner SF, Young MA (1986) Subtypes of β-adrenergic receptors in bovine coronary arteries. Circ Res 59:463–473
Vatner SF (1980) Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 47:201–207
Vatner SF, Hintze TH (1983) Mechanism of constriction of large coronary arteries by β-adrenergic receptor blockade. Circ Res 53:389–400
Vatner SF, McRitchie RJ (1975) Interaction of the chemoreflex and the pulmonary inflation reflex in the regulation of coronary circulation in conscious dogs. Circ Res 37:664–673
Vatner SF, Hintze TH, Macho P (1982) Regulation of large coronary arteries by β-adrenergic mechanisms in the conscious dog. Circ Res 51:56–66
Vekshtein VI, Yeung AC, Vita JA, Nabel EG, Fish RD, Bittl JA, Selwyn AP, Ganz P (1989) Fish oil improves endothelium-dependent relaxation in patients with coronary artery disease. Circulation 80 (Suppl II):II-434 (abstract)
Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58:552–564
Verbeuren TJ, Jordaens FH, Van Hove CE, von Hoydonck AE, Herman AG (1990) Release and vascular activity of the endothelium-derived relaxing factor in atherosclerotic aorta. Eur J Pharmacol (in press)
Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491–497
Vlahakes GJ, Baer RW, Uhlig PN, Verrier ED, Bristow JD, Hoffman JIE (1982) Adrenergic influence in the coronary circulation of conscious dogs during maximal vasodilation with adenosine. Circ Res 51:371–384
Von Restorff W, Bassenge E (1977) Transient effects of norepinephrine on myocardial oxygen balance. Pfluegers Arch 370:131–137
Von Restorff W, Holtz J, Bassenge E (1977) Exercise induced augmentation of myocardial oxygen extraction in spite of normal coronary dilatory capacity in dogs. Pfluegers Arch 372:181–185
Vrints C, Verbeuren TJ, Snoeck J, Herman AG (1990) Effects of hypercholesterolemia on coronary vascular reactivity. In: Rubanyi GM, Vanhoutte PM (eds) Endothelium-derived contracting factors. Karger, Basel, pp 162–168
Wainwright CL, Parratt JR (1988) The effect of L655,240, a selective thromboxane and prostaglandin endoperoxide antagonist, on ischemia-and reperfusion-induced cardiac arrhythmias. J Cardiovasc Pharmacol 12:264–271
Wang H-H, Katz RL (1965) Effects of changes in coronary blood pH on the heart. Circ Res 17:114–122
Wargovich T, Mehta J, Nichols WW, Pepine CJ, Conti CR (1985) Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. J Am Coll Cardiol 6:1047–1051
Weitzell R, Tanaka T, Starke K (1979) Pre-and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol 308:127–136
Wennmalm A, Lanne B, Petersson A-S (1990) Detection of endothelium-derived relaxing factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal Biochem 197: (in press)
Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B (1989) Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 79:287–291
Wiggers CJ (1954) The interplay of coronary vascular resistance and myocardial compression in regulating coronary flow. Circ Res 2:271–279
Wilson FR, Marcus ML, White CW (1988) Pulmonary inflation reflex: its lack of physiological significance in coronary circulation of humans. Am J Physiol 255:H866–H871
Wilson FR, Lesser JR, Laxson DD, White CW (1989) Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet I:807–811
Winniford MD, Filipchuk N, Hillis LD (1983) Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation 67:1185–1188
Woodman OL, Vatner SF (1987) Coronary vasoconstriction mediated by α1-and α2-adrenoceptors in conscious dogs. Am J Physiol 253:H388–H393
Wright CD, Mülsch A, Busse R, Osswald H (1989) Generation of nitric oxide by human neutrophils. Biochem Biophys Res Comm 160:813–819
Wright CE, Angus JA (1986) Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit. Hypertension 8:361–371
Wüsten B, Buss DD, Deist H, Schaper W (1977) Dilatory capacity of the coronary circulation and its correlation to the arterial vasculature in the canine left ventricle. Basic Res Cardiol 72:636–650
Yamaguchi N, DeChamplain J, Nadeau RA (1977) Regulation of norephinephrine release from cardiac sympathetic fibers in the dog by presynaptic α-and β-receptors. Circ Res 41:108–117
Yamamoto Y, Tomoike H, Egashira K, Nakamura M (1987a) Attenuation of endothelium-related relaxation and enhanced responsiveness of vascular smooth muscle to histamine in spastic coronary arterial segments from miniature pigs. Circ Res 61:772–778
Yamamoto Y, Tomoike H, Egashira K, Kobayashi T, Kawasaki T, Nakamura M (1987b) Pathogenesis of coronary artery spasm in miniature swine with regional intimal thickening after balloon denudation. Circ Res 60:113–121
Yanagisawa M, Masaki T (1989a) Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10:374–378
Yanagisawa M, Masaki T (1989b) Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38:1877–1883
Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T (1988) Endothelium-derived novel vasoconstrictor peptide endothelin: a possible endogenous agonist for voltage-dependent Ca2+ channels. In: Morad M, Nayler W, Kazda S, Schramm M (eds) The calcium channel: structure, function and implications. Springer, Berlin Heidelberg New York, pp 575–585
Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F (1976) Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91:148–155
Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoproteins in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086–1095
Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y (1989) Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Comm 161:859–864
Young MA, Knight DR, Vatner SF (1987) Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 30:211–234
Young MA, Knight DR, Vatner SF (1988a) Parasympathetic coronary vasoconstriction induced by nicotine in conscious calves. Circ Res 62:891–895
Young MA, Vatner DE, Knight DR, Graham RM, Homcy CJ, Vatner SF (1988b) α-adrenergic vasoconstriction and receptor subtypes in large coronary arteries of calves. Am J Physiol 255:H1452–H1459
Zeiher AM, Drexler H, Wollschläger H, Just H (1989a) Preserved flow-mediated vasodilation despite acetylcholine-induced vasoconstriction in atherosclerotic coronary arteries in man. J Am Coll Cardiol 13 (Suppl A):132A (abstract)
Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H (1989b) Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14:1181–1190
Zimmerman BG (1978) Actions of angiotensin on adrenergic nerve endings. Fed Proc 37:199–202
Zucker IH, Cornish KG, Hackley J, Bliss K (1987) Effects of left ventricular receptor stimulation on coronary blood flow in conscious dogs. Circ Res 61 (Suppl II):II54–II60
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag
About this chapter
Cite this chapter
Bassenge, E., Heusch, G. (1990). Endothelial and neuro-humoral control of coronary blood flow in health and disease. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 116. Reviews of Physiology, Biochemistry and Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3540528806_4
Download citation
DOI: https://doi.org/10.1007/3540528806_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52880-7
Online ISBN: 978-3-540-47169-1
eBook Packages: Springer Book Archive